{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T04:44:14Z","timestamp":1743655454736},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,3]]},"DOI":"10.7759\/cureus.15413","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T10:21:50Z","timestamp":1622715710000},"source":"Crossref","is-referenced-by-count":2,"title":["Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade"],"prefix":"10.7759","author":[{"given":"Joshua A","family":"Goodner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric  J","family":"Likar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail L","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M","family":"Quedado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpan","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavithra","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"BRIDION\u00ae (sugammadex) Injection. (2015). Accessed. June 2, 2021: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/022225lbl.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31818a3fee","article-title":"Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine","volume":"109","author":"Jones RK","year":"2008","unstructured":"Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology. 2008, 109:816-24. 10.1097\/ALN.0b013e31818a3fee","journal-title":"Anesthesiology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000248224.42707.48","article-title":"Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine","volume":"104","author":"Sacan O","year":"2007","unstructured":"Sacan O, White PF, Tufanogullari B, Klein K. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Anesth Analg. 2007, 104:569-74. 10.1213\/01.ane.0000248224.42707.48","journal-title":"Anesth Analg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0b013e32833d56b7","article-title":"Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial","volume":"27","author":"Blobner M","year":"2010","unstructured":"Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol. 2010, 27:874-81. 10.1097\/EJA.0b013e32833d56b7","journal-title":"Eur J Anaesthesiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/anae.13277","article-title":"A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade","volume":"70","author":"Abad-Gurumeta A","year":"2015","unstructured":"Abad-Gurumeta A, Ripoll\u00e9s-Melchor J, Casans-Franc\u00e9s R, et al.. A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade. Anaesthesia. 2015, 70:1441-52. 10.1111\/anae.13277","journal-title":"Anaesthesia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/57849-clinical-impact-of-sugammadex-in-the-reversal-of-neuromuscular-blockade","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:58Z","timestamp":1707507298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/57849-clinical-impact-of-sugammadex-in-the-reversal-of-neuromuscular-blockade"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.15413","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,3]]}}}